- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04128592
Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers (NiNbI)
October 15, 2019 updated by: Marc Raes, Hasselt University
Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers Based on Biomarker Profiles in Exhaled Breath and Nasal Mucus and Based on Breath Sound Analysis
Almost 50% of all children have at least 1 episode of noisy breathing before the age of 2 years and almost 25% of these children have more episodes of noisy breathing.
The lack of an objective technique for diagnosing noisy breathing children often leads to overrated diagnosis of "wheezing", whereas there may be other noisy breathing phenotypes, like "rattling", that don't favor from the same therapeutic treatment.
Presumably, different underlying pathophysiological mechanisms are involved with different biomarker profiles characteristic for different phenotypes.
The goal of this study is to optimize the diagnosis of noisy breathing infants and toddlers.
Children will be followed for a treatment period of 6 weeks and will visit the paediatrician 3 times (week 0, 3 and 6).
During the consultations breath sound analysis will be performed and a breath sample and a nasal mucus will be collected to analyse biomarker profiles.
Both methods for diagnosing noisy breathing infants are non-invasive and will be compared to the standard procedure of the paediatrician which consists of auscultation and palpation of the chest.
An objective and non-invasive method for diagnosing noisy breathing infants and toddler will pave the way for more cost-effective and personalized prescription of therapies which will increase the quality of life of children with noisy breathing.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Marc Raes, prof. dr.
- Phone Number: +32 11 30 84 65
- Email: marc.raes@jessazh.be
Study Contact Backup
- Name: Gitte Slingers, drs.
- Phone Number: +32 11 30 84 65
- Email: gitte.slingers@uhasselt.be
Study Locations
-
-
-
Hasselt, Belgium, 3500
- Recruiting
- Jessa Ziekenhuis
-
Contact:
- Gitte Slingers, drs.
- Phone Number: + 32 11 30 84 65
- Email: gitte.slingers@uhasselt.be
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 months to 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- clinical diagnosis of noisy breathing ("wheezing" or "rattling")
Exclusion Criteria:
- born before pregnancy week 37
- congenital or genetic conditions (Down syndrome, Klinefelter's syndrome, …)
- acquired chronic respiratory diseases (bronchopulmonary dysplasy, lung fibrosis, …)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Wheezing
|
breath sampling and nasal mucus sampling to analyze biomarkers and breath sound analysis to diagnose noisy breathing.
|
Other: Rattling
|
breath sampling and nasal mucus sampling to analyze biomarkers and breath sound analysis to diagnose noisy breathing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation
Time Frame: week 0
|
Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.
|
week 0
|
Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation
Time Frame: week 3
|
Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which
differentiate "wheezing" and "rattling" infants and toddlers.
Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation.
|
week 3
|
Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation
Time Frame: Week 6
|
Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which
differentiate "wheezing" and "rattling" infants and toddlers.
Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation.
|
Week 6
|
exhaled breath volatiles
Time Frame: week 0
|
exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)
|
week 0
|
exhaled breath volatiles
Time Frame: week 3
|
exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)
|
week 3
|
exhaled breath volatiles
Time Frame: week 6
|
exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS)
|
week 6
|
respiratory pathogens
Time Frame: week 0
|
respiratory pathogens present in a nasopharyngeal swab detected using PCR
|
week 0
|
respiratory pathogens
Time Frame: week 3
|
respiratory pathogens present in a nasopharyngeal swab detected using PCR
|
week 3
|
respiratory pathogens
Time Frame: week 6
|
respiratory pathogens present in a nasopharyngeal swab detected using PCR
|
week 6
|
level of inflammation markers
Time Frame: week 0
|
level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay
|
week 0
|
level of inflammation markers
Time Frame: week 3
|
level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay
|
week 3
|
level of inflammation markers
Time Frame: week 6
|
level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay
|
week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breath sound recordings evaluated by expert panel of pediatricians
Time Frame: week 0
|
Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.
|
week 0
|
Breath sound recordings evaluated by expert panel of pediatricians
Time Frame: week 3
|
Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.
|
week 3
|
Breath sound recordings evaluated by expert panel of pediatricians
Time Frame: week 6
|
Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording.
|
week 6
|
Treatment response assessed by online journal for parents
Time Frame: week 6
|
Parents are asked what type of noisy breathing symptoms their child had during the day.
Options are: (1) Wheezing; (2) Rattling; (3) Both, but mostly wheezing; (4) Both, but mostly rattling; (5) Both in equal amounts, (6) No noisy breathing today.
In the online questionnaire sound fragments of wheezing and rattling are available incase parents are in doubt.
|
week 6
|
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 3 months after week 6
|
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness.
In the online
|
3 months after week 6
|
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 6 months after week 6
|
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness.
In the online
|
6 months after week 6
|
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 9 months after week 6
|
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness.
In the online
|
9 months after week 6
|
Recurrence of symptoms assessed by follow up questionnaire
Time Frame: 12 months after week 6
|
Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness.
In the online
|
12 months after week 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marc Raes, prof. dr., Jessa Hospital
- Study Chair: Gitte Slingers, drs., Hasselt University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 30, 2018
Primary Completion (Anticipated)
March 1, 2020
Study Completion (Anticipated)
May 1, 2020
Study Registration Dates
First Submitted
August 27, 2019
First Submitted That Met QC Criteria
October 15, 2019
First Posted (Actual)
October 16, 2019
Study Record Updates
Last Update Posted (Actual)
October 16, 2019
Last Update Submitted That Met QC Criteria
October 15, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NiNbI-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wheezing
-
OM Pharma SAParexelRecruitingRecurrent Wheezing | Wheezing Lower Respiratory IllnessUnited States
-
Assistance Publique - Hôpitaux de ParisRevenio ResearchRecruitingHealthy, Wheezing, Non Wheezing Acute Respiratory EpisodeFrance
-
University of OuluRecruiting
-
OM Pharma SARecruitingRespiratory Tract Infections | Wheezing Lower Respiratory IllnessUnited Kingdom, Hungary, Poland, Switzerland, Germany, Italy
-
UMC UtrechtKU Leuven; Maastricht University Medical Center; Universiteit Antwerpen; Université...Withdrawn
-
Istituto per la Ricerca e l'Innovazione BiomedicaCompleted
-
KarmelSonix Ltd.Unknown
-
University of TurkuAcademy of FinlandUnknown
-
Queen Mary University of LondonUniversity of Leicester; University of AberdeenCompleted
-
Universita di VeronaAzienda Ospedaliera Universitaria PoliclinicoUnknown
Clinical Trials on diagnosing noisy breathing in infants and toddlers
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompletedHand, Foot and Mouth DiseaseChina
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompletedThe Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and InfantsChina
-
Sonova AGCompletedHearing Loss, Bilateral | Hearing Loss, UnilateralGermany
-
University of PatrasRecruitingRespiratory Disease | Infant, Newborn, Disease | Respiratory Function TestsGreece
-
Jawaharlal Institute of Postgraduate Medical Education...CompletedOrotracheal Intubation in Infants Requiring General Anaesthesia for SurgeryIndia
-
Hacettepe UniversityCompleted
-
University of California, DavisNational Institute of Mental Health (NIMH); University of California, Los Angeles and other collaboratorsCompletedAutism Spectrum Disorder | AutismUnited States
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompletedThe Efficacy of Inactivated EV71 Vaccine (KMB17) Against HFMD in Chinese Children and InfantsChina
-
National Jewish HealthWithdrawnEczema | Atopic Dermatitis | Food AllergyUnited States
-
Tanta UniversityRecruitingVentral Hernia | Incisional Hernia | Abdominal Wall WoundEgypt